2017 Population Health Summit
A pioneer in the field of healthcare investing, Dr. Mitchell Blutt holds a degree from the University of Pennsylvania School of Medicine. The first medical doctor in the healthcare investment business, Mitchell Blutt currently applies his expertise as the CEO of Consonance Capital and he is also a member of the New York Academy of Medicine.
The New York Academy of Medicine is a public health organization that specializes in urban health advocacy. Founded in 1847, the organization actively engages in research and policy studies in addition to other programming initiatives and events for those engaged in the public health professions.
One such event, the 2017 Population Health Summit, is scheduled for December 11, 2017, at the academy’s facility in New York City. The New York State Health Foundation is sponsoring the summit, which focuses on population health and the many factors that can affect it. For example, past workshops have addressed the importance of coordination between the health care and social service sectors as well as the non-medical determinants of a population’s overall health. Additional information on this year’s event, which is designed as a retrospective on the successes and challenges of all four past summits, can be found at www.nyam.org.
As CEO of Consonance Capital, Dr. Mitchell Blutt guides private equity funds and health care investments. Community focused, Dr. Mitchell Blutt supports a number of nonprofits and is a past board member of the Michael J. Fox Foundation, which is working to find a cure for Parkinson’s disease.
Impacting 10 million people across the globe, Parkinson’s disease is a neurological condition that results in deterioration of physical function, with uncontrollable tremors leading to nerve cells misfiring and dying within the brain. Still incurable, Parkinson’s disease is not fully understood by medical researchers.
A recently published study by the Okinawa Institute of Science and Technology Graduate University revealed the protein that blocks the proper transmission of neural signals that underpin higher brain functioning. Neurotransmission enables neurons to communicate signals effectively and transfer them in ways that allow seamless sensory motor functioning.
The chemical messengers contained in vesicle endocytosis within the nerve terminal are essential in transmitting neurological signals. When the process of endocytosis is inhibited during times of heavy use, processes breakdown and sensory perception of motor control is affected. Understanding this inhibitory process promises to offer a vital step toward tailoring treatments to actual neurological conditions in ways that have a positive for among patients.
Healthcare investment professional Dr. Mitchell Blutt founded Consonance Capital in 2005 and has served as its CEO since then. An active member of the healthcare community, Dr. Mitchell Blutt has been involved with various healthcare foundations such as the Michael J. Fox Foundation.
Each year, the Michael J. Fox Foundation works toward the goal of curing Parkinson’s disease by funding crucial research and supporting the creation of innovative therapies. Focused primarily on improving the lives of Parkinson’s patients, the organization also provides all the information individuals need to understand their various treatment options.
Medication is one of the first therapies physicians recommend to those living with Parkinson’s disease. Though these prescriptions help lessen symptoms of the condition, they cannot slow or reverse the disease itself. In general, Parkinson’s disease medications target two sets of symptoms: motor and non-motor. The former helps alleviate the muscle tremors and sluggishness that the condition manifests in patients. The latter complements physical treatment by providing relief from symptoms such as sleep deprivation and depression.
When medications are not enough to help patients manage their symptoms, physicians often will turn to deep brain stimulation as an alternative method of treatment. Those who receive this therapy must undergo a surgical procedure in which they receive electrode implants in their brain. By connecting to an external device, these electrodes administer small pulses to the parts of the brain that generate motor symptoms.
New York Academy of Medicine
A physician and business leader focused on healthcare investment, Dr. Mitchell Blutt serves as CEO of Consonance Capital, a New York City-based firm he founded in 2005. Additionally, he has taught as a professor at Weill Cornell Medical College for nearly three decades. Over the course of his career, Dr. Mitchell Blutt has maintained memberships in organizations such as The New York Academy of Medicine.
In addition to pursuing various research, policy, and program initiatives, The New York Academy of Medicine oversees a library that features a world-renowned collection of texts and other materials on medicine and public health. Recently, the Academy announced that Kriota Willberg will serve as the library’s first-ever Artist in Residence.
Willberg, a visual artist who teaches musculoskeletal anatomy to other artists as well as dancers and massage therapists, has collaborated with the academy in the past on anatomy drawing workshops and demonstrations. As the library’s Artist in Residence, she will explore the intersections between art and the body sciences and will hold workshops and classes for peers and students.
More information about Kriota Willberg and her appointment as the Artist in Residence at the New York Academy of Medicine’s library can be found at www.nyam.org/news.